AUGX Stock Overview
Provides remote medical documentation solutions and live clinical support services in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Augmedix, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.92 |
| 52 Week High | US$6.25 |
| 52 Week Low | US$0.90 |
| Beta | 0.064 |
| 1 Month Change | -66.12% |
| 3 Month Change | -77.55% |
| 1 Year Change | -77.16% |
| 3 Year Change | -84.67% |
| 5 Year Change | n/a |
| Change since IPO | -81.64% |
Recent News & Updates
Recent updates
Is Augmedix, Inc. (NASDAQ:AUGX) Trading At A 40% Discount?
May 21
Augmedix, Inc. (NASDAQ:AUGX) Shares Slammed 29% But Getting In Cheap Might Be Difficult Regardless
Apr 25Augmedix: Secular AI Tailwinds, But Still Unattractive Risk-Reward
Mar 24Augmedix, Inc. (NASDAQ:AUGX) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Nov 09Augmedix reports Q2 results
Aug 08Augmedix: A Splendid Long-Term Investing Opportunity
Jan 21Shareholder Returns
| AUGX | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | -19.5% | -8.5% | -0.6% |
| 1Y | -77.2% | -20.3% | 22.5% |
Return vs Industry: AUGX underperformed the US Healthcare Services industry which returned -20.3% over the past year.
Return vs Market: AUGX underperformed the US Market which returned 22.5% over the past year.
Price Volatility
| AUGX volatility | |
|---|---|
| AUGX Average Weekly Movement | 17.6% |
| Healthcare Services Industry Average Movement | 9.5% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: AUGX's share price has been volatile over the past 3 months.
Volatility Over Time: AUGX's weekly volatility has increased from 12% to 18% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 1,430 | Manny Krakaris | www.augmedix.com |
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient’s health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones.
Augmedix, Inc. Fundamentals Summary
| AUGX fundamental statistics | |
|---|---|
| Market cap | US$44.96m |
| Earnings (TTM) | -US$20.43m |
| Revenue (TTM) | US$48.70m |
0.9x
P/S Ratio-2.2x
P/E RatioIs AUGX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AUGX income statement (TTM) | |
|---|---|
| Revenue | US$48.70m |
| Cost of Revenue | US$25.22m |
| Gross Profit | US$23.48m |
| Other Expenses | US$43.91m |
| Earnings | -US$20.43m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.42 |
| Gross Margin | 48.22% |
| Net Profit Margin | -41.95% |
| Debt/Equity Ratio | 115.0% |
How did AUGX perform over the long term?
See historical performance and comparison